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A B S T R A C T
Among mammals, milk constituents directly influence the ecology of the infant’s commensal micro-
biota. The immunological and nutritional impacts of breast milk and microbiota are increasingly well
understood; less clear are the consequences for infant behavior. Here, we propose that interactions
among bioactives in mother’s milk and microbes in the infant gut contribute to infant behavioral
phenotype and, in part, have the potential to mediate parent–offspring conflict. We hypothesize that
infant behavior likely varies as a function of their mother’s milk composition interacting with the infant’s
neurobiology directly and indirectly through the commensal gut bacteria. In this article, we will explore
our hypothesis of a milk-microbiota-brain-behavior dynamic in the context of the coevolution between
human milk oligosaccharides, bacteria, the gut–brain axis and behavior. Integrating established features
of these systems allows us to generate novel hypotheses to motivate future research and consider
potential implications of current and emerging clinical treatments.
K E Y W O R D S : human milk oligosaccharides; commensal bacteria; microbiota; maternal investment;
infant development; lactation
INTRODUCTION
Mammalian infants are reliant on their mother’s
milk for survival, as are their coevolved gut micro-
biota. Infants are primarily exposed to complex mi-
crobial communities perinatally during vaginal birth
and throughout infancy, with milk constituents dir-
ectly influencing the ecology of the infant’s com-
mensal microbiota [1–4]. Within this exquisitely
complex, dynamic system, hundreds of bacterial
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species and a wide array of milk components inter-
act, affecting immune function and bioavailability of
nutrients. Research effort has predominantly, and
understandably, been directed to the immunological
and nutritional impacts of breast milk and micro-
biota from both clinical and evolutionary perspec-
tives [4–9]. Meanwhile, the intersections among
mother’s milk, microbial ecology and the gut–brain
axis, and the consequences for infant behavior, have
yet to be investigated. Here, we propose that inter-
actions between bioactives in mother’s milk and mi-
crobes in the infant gut contribute to infant
behavioral phenotype and, in part, have the potential
to mediate parent–offspring conflict and coordin-
ation (Fig. 1). We hypothesize that infant affect
and behavior—crying, suckling, activity, emotional-
ity—in breastfed infants likely varies as a function of
their mother’s milk composition interacting with the
infant’s neurobiology and physiology directly and in-
directly through the commensal gut bacteria. In this
article, we will explore our hypothesis in the context
of the coevolution between human milk oligosac-
charides (HMO) and bacteria, with implications
for neonatal brain and behavior. In addition, we will
consider potential interactions with maternal-origin
hormones, previously demonstrated to affect off-
spring biobehavioral organization. Integrating es-
tablished features of these systems allows the
generation of novel hypotheses to motivate future
research, especially in light of potential clinical im-
plications and applications.
THE COMPLEXITY OF MOTHER’S MILK
Mother’s milk is a complexly structured, highly
personalized biological fluid transferring bioactive
constituents to the developing neonate [1, 10, 11].
The presence and relative abundance of individual
milk bioactives vary as a function of maternal gen-
etic, pathogenic, somatic, life-historic, phylogenetic
and environmental characteristics. In addition to the
calories from macroconstituents, mother’s milk also
provides the infant with immunoglobulins, min-
erals, hormones and oligosaccharides [11]. Milk
oligosaccharides are variably structured chains of
sugars with a lactose core [10, 12]. These complex
sugars are found across mammalian taxa, but the
oligosaccharide profiles in milk are highly variable
among species [12]. In humans, milk oligosacchar-
ides are the third most plentiful component of milk
and likely represent a substantial proportion of lac-
tation effort.
The diversity, complexity and abundance of HMO
show evidence of divergence from other primates,
suggesting the oligosaccharides in human milk have
been a target of natural selection [11, 13]. The par-
ticular profile of oligosaccharides an individual
mother produces is variable, heritable and can be
associated with fitness proxies [7, 12, 14, 15]. To
date, hundreds of oligosaccharides have been
identified in human milk [16]. Humans produce a
greater diversity and higher abundance of oligosac-
charides than do any of the apes, monkeys or
strepsirrhines investigated to date, typically by an
order of magnitude [11]. Despite the diversity of po-
tential HMO, individual mothers produce only a
subset, generally 50 [17]. This subset, or HMO
profile, varies by presence, abundance and propor-
tion of particular HMO isomers. One known pre-
dictor of the HMO profile a mother produces is her
secretor status, determined by specific alleles
encoding fucosyltransferases (e.g. FUT2 gene) that
attach fucose sugars to HMO, creating fucosylated
HMO [10, 17]. Mothers without secreter alleles,
known as non-secretors, produce a much more
limited amount of fucosylated HMO [15, 18].
Additionally, HMO profiles change over the course
of lactation—the presence and prevalence of par-
ticular isomers shift while the total proportion of
HMO in milk declines [15, 18].
Figure 1. Conceptual model of bioactives in milk mediating
maternal-offspring conflict and coordination. Bioactives in
milk affect gut microbiota in the infant, impacting the devel-
opment of neurobiology and subsequently behavior.
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MOTHER’S MILK AND INFANT GUT
MICROBIOTA
Mothers’ HMO profiles have been associated with
the establishment and maintenance of commensal
bacteria [3, 4, 19, 20]. HMO are not primarily di-
gested by the infant for nutrition as they remain
largely intact during passage to the colon [4]. Once
in the colon, HMO can be metabolized by intestinal
microbiota able to enzymatically cleave the HMO
bonds [3, 4]. As the infant’s gut matures, ecological
succession occurs and anaerobic bacteria belonging
to genera such as Bifidobacterium and Bacteroides
become numerically dominant [3]. Notably, select
bifidobacterial genomes contain unique gene clus-
ters that enable efficient HMO metabolism [21, 22].
This is consistent with their frequent overrepre-
sentation in the infant gut microbial community
[22]. In addition, Bacteroides possess mucus utiliza-
tion pathways to consume structurally similar sol-
uble HMO [23]. The ability of the infant’s
commensal gut microbiota—but not the infant’s en-
dogenous enzymes—to digest milk oligosacchar-
ides suggests that mothers are feeding bacteria, too.
HMO profiles also influence infant susceptibility
to viral and bacterial pathogens [3, 18, 24]. Milk
oligosaccharides passing through the infant’s
gastrointestinal tract can bind to virus or bacterial
strains like rotavirus, Escherichia coli, Campylobacter
jejuni and Vibrio cholerae [4, 18, 20]. Protection from
these diarrheal diseases, a leading cause of infant
mortality, is expected to be a major selection pres-
sure [25]. Fucosylated HMO are better ‘decoys’ for
Camplyobacter, E.coli and norovirus, as the fucosyl
portion of the molecule are similar to those pre-
sented on the gut epithelium to which pathogens
bind [24, 25]. However, non-fucosylated HMO also
protect against serious pathogens, like rotavirus
[25]. Additionally, HMO discourage the establish-
ment of pathogens in the gut through supporting
the growth of specific bacteria. The beneficial bac-
teria attached to the gut epithelium become com-
petitive inhibitors of pathogenic invaders, protecting
the infant from disease [22].
MICROBIAL FUNCTIONS IN THE
INFANT GUT
The community structure of the infant gut, shaped in
part by mother’s milk, is instrumental for the infant’s
physiological development [3, 20, 26]. The gut bac-
teria are important for programming early immune
responses, bioconverting ingested nutrients and in-
hibiting pathogenic bacteria [20]. Gut microbiota
synthesize vitamins necessary to the host and fer-
ment carbohydrates that are otherwise indigestible
[22]. Metabolism of such carbohydrates may also
increase the bioavailability of minerals, like iron, to
the host [27]. Bacteria in the gut also produce short-
chain fatty acids capable of crossing the blood–brain
barrier and impacting the synthesis of neurotrans-
mitters [28]. Exposure to gut microbiota in infancy
also appears to ‘prime’ the immune system and dis-
turbances in early gut microbiota have been
associated with auto-immune and allergic diseases
[8]. The microbial transfer from mother to offspring
is an important aspect of natal development that
continues into infancy as microbes are fed by the
mother [29]. The infant intestinal microbiome and
the potentially adaptive capacity to synthesize HMO
likely coevolved in response to selective regimes that
exerted particularly strong pressures on immunity,
nutrient intake and the mother–offspring relation-
ship during infancy in human evolution.
BODY AND BRAIN
Gut–brain axis
The gut and brain communicate in bidirectional
pathways along the gut–brain axis (Fig. 2).
Although the main signaling route between the
gut and brain is the vagus nerve connecting the
enteric nervous system to the brain, immunological
and hormonal interactions also exist [9]. Aberrant
assembly of intestinal microbiota (i.e. dysbiosis)
can activate an inflammatory response that induces
depressive-like sickness behaviors and impairs
cognition [30]. Gut microbiota can also release mol-
ecules that function as neurotransmitters in their
host, like catecholamines [9, 31]. Catecholamines
produced by the host also affect the gut, as
indicated by a seven log-fold rise in E.coli after sys-
temic release of catecholamines in response to
neurotoxin administration [31]. Exposure to mi-
crobes also increases the cannabinoid and opioid
receptors in the rodent intestine [9]. These neuro-
logical and endocrine pathways of the gut–brain
axis develop in the first 1000 days of life, as brain
size doubles, cortical neurogenesis occurs, the
hypothalamic–pituitary–adrenal (HPA) axis be-
comes regulated and the mucosal barrier of the
gut strengthens [2, 6, 7, 32, 33].
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HPA axis
The HPA axis controls the release of the glucocortic-
oids that are instrumental in metabolic, immune
and biobehavioral responsivity and regulation [34,
35]. The HPA axis is an endocrine cascade: cortico-
trophin-releasing hormone is secreted from the
hypothalamus, which binds to receptors in the an-
terior pituitary stimulating the release of adrenocor-
ticotropin hormone (ACTH) that then passes into
circulation and stimulates the secretion of gluco-
corticoids from the adrenal glands [26, 32, 34].
Acute upregulation of the HPA axis occurs when
an organism is confronted by situational challenges
and motivates the ‘fight or flight’ response, as well as
orchestrates accompanying metabolic, immunolo-
gical and behavioral responsivity. At baseline, how-
ever, glucocorticoids follow a diurnal rhythm and
maintain essential homeostatic functions in the
body, such as catabolism of fat stores [32, 35].
Importantly, the HPA axis underlies stable individual
differences in behavioral phenotype, known variably
as personality, temperament and behavioral syn-
dromes [36]. In this way, the HPA axis importantly
underlies the biobehavioral regulation of individ-
uals. Moreover, signaling pathways originate in the
brain and glucocorticoid receptors are found in tis-
sues throughout the body, including the intestinal
tract, creating multiple intersections between the
HPA and gut–brain axis. The concentration and ex-
pression of glucocorticoid receptors in the intestinal
tract are particularly high during infancy when in-
fants are receiving maternal-origin glucorticoids
via milk and are seemingly co-organizing neurobio-
logical and behavioral development [35–37].
INTERSECTING PATHWAYS OF THE HPA
AND GUT–BRAIN AXES
Interactions between the HPA and gut–brain axes
have been demonstrated in adult germ-free rodent
models that display aberrant behavioral phenotypes
[38]. Germ-free mice have higher plasma levels of
ACTH and glucocorticoids in response to being
physically restrained—a stressful manipulation—
compared with specific-pathogen free (SPF) mice
[39]. However, gnotobiotic mice that were colonized
only by Bifidobacterium longum subsp. infantis ex-
hibited glucocorticoid secretion equivalent to the re-
sponse of SPF mice [39]. The increased
glucocorticoid response in germ-free mice is also
alleviated by inoculation with SPF feces; however,
this intervention was only effective at juvenility and
possibly transitions to adulthood [39]. From these
studies, we can infer neurological development of
the animal must occur in concert with colonization
Figure 2. The gut–brain axis pathways by which gut microbiota can affect neurobiology and subsequently behavior. Bacteria
(blue rods and olive green circles) can produce neurotransmitters (yellow circles) or extract them from the gut lumen.
Neurotransmitters can then interact with nerve cells of the vagus nerve or be released into portal circulation and possibly interact
with other nerve cells. Microbiota can induce immune cell (red circles) activation or release hormones (purple circles). Bacterial
species can also competitively inhibit other species, effectively selecting the metabolites able to be produced in the gut.
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of the microbiota to have effects on certain aspects
of biobehavioral phenotype [2, 40]. Among humans,
the first 1000 days is a sensitive period of intense
maternal effort and critical developmental windows
during which infants are particularly sensitive to en-
vironmental and maternal conditions [41]. During
infancy, maternal-origin hormones ingested via milk
shape growth, development and behavior [36, 42].
Concurrently, maternally and environmentally
transferred microbes colonize the infant, partly as
a function of milk oligosaccharides [4]. As such,
the HPA axis, the gut–brain axis, their intersections
and their influences on infant behavior are likely
shaped by mother’s milk.
MICROBIAL INFLUENCES ON HOST
BEHAVIOR
The community structure of gut microbiota influ-
ences host behavior [9]. Research with gnotobiotic
mice has demonstrated that gut microbial coloniza-
tion affects social and anxiety-like behavior [33, 40,
43]. Germ-free mice without intestinal microbiota
deviate from species-typical behavior; they are less
social and do not prefer novel over familiar mice [40].
Additionally, species-typical microbiota coloniza-
tion manifests a more exploratory, less nervous be-
havioral phenotype than displayed by germ-free
mice [44]. Colonizing adult rodents with one or two
strains of Bifidobacterium spp. or Bacteroides spp.
can improve behavioral phenotype, including a par-
tial recovery of social behavior, reduced anxiety and
decreased stereotyped behavior [43, 45, 46]. This is
particularly salient given that several species belong-
ing to these two genera have been demonstrated to
metabolize HMO [23].
Conversely, for the individual, challenging
experiences can alter gut microbial ecology with
persistent effects months later [28]. Bifidobacteria
and Lactobacillus populations are reduced in infant
rhesus macaques stressed prenatally by maternal
exposure to an acoustic startle [47], suggesting
these bacterial genera may be especially vulnerable
to host stress. Given bifidobacteria’s sensitivity to
host stress, it may be advantageous that its host
remains calm, potentially explaining the role of some
strains in reducing anxious behavior and stress re-
activity in the host [48]. Maternal separation models
have also induced changes in offspring microbial
ecology, including the reduction of Lactobacillus [28].
Milk bioactives encourage the growth of specific
gut bacteria that may produce particular behavioral
phenotypes. Infants with colic, a syndrome marked
by extensive crying, have less diverse microbiota
than healthy infants [49]. However, symptoms of
colic were significantly reduced after inoculation
with lactic acid bacteria, specifically Lactobacillus
reuteri [22, 50]. L.reuteri also reduces the duration
of acute infectious diarrhea in infants and children
[51]. Infants with higher concentrations of
bifidobacteria in their gut also exhibited less crying
and fussing in the first 3 months of life [52]. Although
these effects may be due in part to alleviation of
gastrointestinal distress, we speculate that HMO
in mother’s milk may function to promote the col-
onization of microbiota that influence offspring
biobehavioral regulation in concert with immune
and nutritional effects.
There has not, to our knowledge, been a published
study that experimentally or observationally
investigated the potential effects of HMO or other
milk bioactives on the microbial community struc-
ture/function and resultant behavioral phenotype in
model organisms or humans. Recently, microbiota
composition and temperament have been
associated in children aged 18–27 months [53].
Breastfeeding duration, as a dichotomous variable,
did not have a significant effect on temperament
factors associated with gut microbial profiles; how-
ever, the presence and abundance of HMO or other
‘biobehavioral’ milk bioactives were not examined
[53]. Nonetheless, this research represents a crucial
step forward, as the majority of studies
demonstrating microbial effects on behavior have
been performed on weaned animals, despite
evidence that colonization within critical early win-
dows is necessary to affect behavioral development
[39, 40].
AN EVOLUTIONARY PUSH–PULL:
PARENT–OFFSPRING CONFLICT
Mammalian mothers and infants engage in complex
behavioral and physiological negotiations to deter-
mine the amount and duration of maternal care and
milk transfer. Parent–offspring conflict is the expect-
ation of an essential tension between mothers and
infants in the preferred amount of maternal invest-
ment that is predicated on their divergent genetic
interests [54–57]. All else being equal, and
acknowledging that rarely is that the case, natural
selection is expected to have shaped adaptations
operating in mothers to equally allocate resources
toward multiple offspring across a reproductive
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career to maximize lifetime reproductive success
[56]. In contrast, the infant being entirely related to
himself, but sharing fewer genes with the mother
and siblings, is expected to manifest adaptations
to extract more resources from the mother than
she is adapted to provide or to use resources accord-
ing to his self-interest [56]. This conflict can be evi-
dent in short-term mother–infant interactions of
infant signals for investment, in how the infant util-
izes maternal investment and the duration of time
until infant independence [36, 54, 56, 58]. For ex-
ample, infant behavioral tactics for eliciting mater-
nal care and milk can be both positive and negative
stimuli—such as nuzzling, smiling, crying and tan-
trums [54, 59].
As infants age, parent–offspring conflict is ex-
pected to intensify as, with each increment of invest-
ment that is provided, the benefit to the mother is
reduced in terms of infant survival and improved
condition [56]. Although the direct fitness of either
increases the inclusive fitness of the other, such that
they each benefit from coordinating behavioral care
and physiological investment, the divergence of in-
fant demand optima and maternal supply optima
increases as infants age [36, 41, 54]. Infants are in-
creasingly more costly; they are bigger and more ac-
tive so their energetic requirements are greater. To
meet that demand, the physiological costs of milk
synthesis increase, diminishing maternal reserves
and potentially extending the period of recovery
until mothers can support subsequent reproduction
[35, 60]. As infants age, they can begin to exploit solid
foods and are not entirely dependent on maternal
nutritional support. As such, from the mother’s per-
spective, costs are increasing and benefits are
decreasing [56, 58]. Mothers, depending on their
physical condition or stage of their reproductive car-
eer, may have more incentive to have lower daily
costs of infant rearing or truncated duration of in-
vestment [60]. For example, adolescent mothers
with fewer resources to sustain lactation may benefit
to a greater extent if their infants have relatively lower
daily energetic costs or behavioral demand [36].
Mothers are expected to have coevolved coun-
termeasures to infant demands for and utilization
of investment, possibly through milk [36, 41, 54, 58].
Milk bioactives have been implicated in shaping in-
fant behavioral phenotype, possibly to more opti-
mally allocate maternal energetic investment.
Collectively, this area of research reveals critical win-
dows of biobehavioral organization, in part sexually
differentiated, and influenced by mother’s milk.
Experimentally elevated glucocorticoids ingested
via mother’s milk demonstrate behavioral and
neurobiological effects persisting into adulthood
[61]. Among rhesus monkeys, glucocorticoids in
milk may contribute to orchestrating infant trade-
offs between growth and behavioral phenotype
[36]. Younger, smaller and less-experienced mothers
produced lower available milk energy but higher cor-
tisol concentrations in milk. The cortisol signal in
milk, independent of available milk energy, pre-
dicted a behavioral phenotype characterized as
more nervous and less exploratory but had greater
daily weight gain during infancy [36]. Speculatively,
hormonal signals in milk may shape infant develop-
mental priorities, influencing infant physiology to
allocate milk energy to growth rather than expensive
behavioral activities like play and exploration [36].
THE DOUBLE-EDGED SWORD OF MILK
OLIGOSACCHARIDES?
The established HMO-microbial interactions,
reducing pathogenic infection and improving nutri-
ent availability in the infant, arguably function to en-
hance return on maternal investment. We
hypothesize along similar lines that HMO in part
shape infant microbial communities to shift infant
behavioral phenotype toward maternal investment
optima by reducing the costs of rearing the infant. If
milk is mediating maternal-offspring conflict
through behavioral effects of the nascent gut micro-
biota, we can make several testable predictions
(Table 1). Particular HMO isomers or HMO profiles
may program the establishment of microbes that
exert biobehavioral effects. We would expect that
HMO would particularly target multifunctional bac-
terial strains that contribute to immunocompetence
and nutrient bioavailability for the infant as well as
behavioral manipulation toward the mother’s op-
tima. In such a situation, there would be no added
cost to the mother to produce the HMO to manipu-
late the infant’s behavioral phenotype, and the yoked
benefits to the manipulation would constrain the
evolution of infant countermeasures [62].
Complicating the dynamics further, particular
HMO isomers or classes of HMO may not necessar-
ily be the target of selection for influencing behav-
ioral phenotype alone; rather, combinations of
HMO acting in concert may be critical to shift mi-
crobial ecology toward maternal optima. Such shifts
may include increased Bifidobacteria, Bacteroides
spp. or Lactobacillus spp. previously implicated in
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Table 1. Hypotheses and predictions for infant behavioral phenotype from maternal, infant and microbial
interactions. Integrating parent-offspring conflict theory, across life history and ecological contexts, we predict
variable manifestations of infant behavioral phenotype as mediated through microbial influences on the brain.
Perspective Hypotheses and Predictions
Maternal (1) Mothers are expected to favor a less costly infant phenotype.
An infant behavioral phenotype that is less energetically costly in terms of maternal caloric transfer could
manifest as:
A Less demanding: elicits less maternal behavioral care, e.g. decreased suckling, crying
B Less energy expenditure: a temperament that has a lower daily energetic budget, e.g. less locomotion,
play, exploration
C Earlier age of independence: less time to weaning threshold, increased reliance on allomothers, faster
attainment of social and foraging skills, more ‘confident’ temperament
Across social, nutritional and ecological contexts:
Reduced energy expenditure is predicted to be particularly favored in risky environments characterized by
infectious disease, injury and predation
Reduced energy expenditure and less demanding behavioral phenotypes expected to be favored under
conditions of low food availability due to ecology (population) and/or access to resources (individual)
Maternal optima in cooperative breeding or biocultural reproduction systems are expected to favor earlier
age of independence from maternal resources and/or more demanding behavior directed to non-mothers.
Across life history:
Young/early reproductive career mothers that are still growing are expected to particularly favor lower infant
energy expenditure.
Prime condition and mid-career mothers are expected to favor an infant behavioral phenotype of earlier
independence to shorten inter-birth intervals.
Mothers favoring an infant phenotype of earlier independence will have an increased metabolic cost at
peak lactation but a faster return to cycling, compared with mothers programming for reduced energetic cost
(2) Milk composition influences microbial communities that shape infant behavioral phenotype.
Mothers predicted to favor particular infant behavioral phenotypes (A, B or C) will produce, in part,
differentiated milk oligosaccharide profiles.
Particular milk oligosaccharide profiles are expected to differentially promote the colonization and maintenance
of microbial communities that affect gut–brain axis regulation and infant neurobiology.
Infant gut microbiota shaped by milk oligosaccharides are predicted to influence regions of the brain underlying
emotion regulation and behavioral motivation to influence a less costly behavioral phenotype
Infant (3) Infants are expected to exhibit some counter-tactics to milk-microbiome-mediated influences on behavior
As infants mature, infant gut physiology becomes less hospitable to milk-oriented microbiota that exert
behavioral influences toward maternal optima.
Infants will increase their exposure to non-maternal bacteria through environmental exposure and
supplemental food to reduce the behavioral influence of milk-oriented microbiota.
Insofar as HMO profiles influence bacteria that simultaneously improve immune response, nutritional
bioavailability and behavioral phenotype, infants may be limited in countering maternal influences on
behavioral phenotype, particularly during early infancy.
Microbial (4) Bacterial influence on infant behavioral phenotype is dependent on bacterial species and phase of infancy.
In early infancy, milk-oriented microbiota in the infant gut will produce a less energetically costly behavioral
phenotype.
As weaning progresses and milk-oriented microbiota receive less milk, these bacteria will neurobiologically
motivate milk demanding behaviors, such as tantrums.
Microbiota that can consume milk oligosaccharides, host glycans and molecules from complementary food
will influence an earlier independence behavioral phenotype to pursue non-maternal foods.
Relevant citations: theoretical motivation: 2, 3, 15, 18, 21, 23, 30, 35, 36, 44, 52, 60, 63, 64–67; relevant empirical research: 2, 9, 19, 20, 35, 36, 56, 58,
59, 68, 69, 70–72
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behavioral outcomes [22, 43, 45, 46]. Alternately, be-
havioral changes may not come from a strict in-
crease in a particular bacterial group; but rather,
proportionate changes may have greater impact.
For example, two infants may have the same amount
of bifidobacteria in their gut, but the overall
proportion of bifidobacteria relative to their other
gut microbiota could be very different. The propor-
tionate interactions with other bacterial genera or
species could drive differences in behavioral
phenotype.
PARENT–OFFSPRING CONFLICT ON A
MICROBIAL LANDSCAPE
Commensal infant bacteria, operating closer to ma-
ternal optima, may influence infants to acquire or
require lower daily investment or shorter duration
of investment (Table 1). Mothers would be expected
to provide less behavioral care and transfer less milk
energy to infants who exhibited fewer signals to elicit
maternal investment (less distress, crying and suck-
ling intensity) [58]. Additionally, reduced energetic
expenditure (less locomotion, exploration and play)
could either decrease daily caloric demand or allow
infants to prioritize growth, thus reaching weaning
thresholds earlier [73]. Among cooperatively
breeding species, like humans [74], a less costly be-
havioral phenotype may increase demand for invest-
ment from non-maternal caretakers, while
decreasing demand for maternal investment. For ex-
ample, a human infant may exhibit increased
smiling, laughter or cuddling but decreased suck-
ling. Cooperatively breeding species may also en-
gage in allo-maternal nursing, where females
provide milk for infants not their own. Although such
a practice might be expected to disrupt the
hypothesized system, the volumes of allo-maternal
milk necessary to swamp the maternal effect would
need to be substantial [75]. Maternally influenced
biobehavioral microbes may also accelerate behav-
ioral development and earlier independence from
the mother but would be less likely in risky nutri-
tional, disease, social or predator ecologies
(Fig. 3). Mothers limited in their capacity to synthe-
size milk or sustain lactation—young, nutritionally
marginal, unhealthy or otherwise constrained—may
particularly benefit from infants characterized by a
less costly behavioral phenotype. A less costly infant
phenotype that is shifted toward the maternal op-
tima is expected to have measurable effects,
including accelerated somatic recovery during the
weaning process, faster returns to cycling, shorter
inter-birth intervals and higher probabilities of suc-
cessful subsequent pregnancies.
Infants may be limited in their counteradapta-
tions to maternally influenced microbial manipula-
tion, especially at younger ages. Currently, to the
best of our knowledge, no pathways have been
described through which infants have the capacity
to influence the HMO profile of the mother.
Moreover, if milk oligosaccharides are instrumental
for infant health and nutrition, constraints while the
immune system is naı¨ve and alternative nutrition is
unavailable may prohibit selection favoring infant
countertactics. However, the infant’s gut physiology
is partially self-organizing, not solely dependent on
maternal and bacterial input [76], opening the door
for countermeasures to discourage the growth or
dominance of microbiota that provides a maternal
advantage, especially as infants mature. Exposure to
non-maternal microbiota could also lessen the im-
pact of maternal manipulation. Infants are exposed
to other microbes through environmental exposure
and complementary foods, especially as they mature
[4, 77].
There is a third party to this parent–offspring con-
flict model: the microbes. The gut microbiota has its
own self-preservation interests that must be con-
sidered [9]. A microbe that increases maternal fit-
ness is more likely to be carried by the mother and
be vertically transmitted to the infant [29]. These mi-
crobes can then benefit the infant through building
immunity and providing nutrient bioavailability,
increasing the fitness of the infant. However, the
microbe’s influences on the infant will also be a tar-
get of selection insofar as they influence the mi-
crobes’ fitness. Although it is counterintuitive to
predict milk-oriented microbes would influence be-
havior to reduce the demand for milk, microbes that
are milk-oriented, such asBifidobacteria infantis, may
have evolved a trade-off: these microbes program for
a less energetically costly phenotype on a daily basis
with the potential to prolong their milk exposure
across infancy. During the weaning process, the
gut undergoes dramatic shifts in microbial compos-
ition because of less milk consumption [2]. As their
numbers decline, milk-metabolizing bacteria may
release toxins or neurochemicals in the absence of
HMO [9]. Toxins interacting with the gut–brain axis
may cause an increase in care-eliciting behaviors, in
an effort to increase milk delivery to the infant and its
microbiota; and these may partially explain the mag-
nitude of weaning tantrums [9, 56]. Additionally,
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microbes that can metabolize HMO and host mucus
glycans or other carbohydrates, like Bacteroides spp.
[9, 23], could program for an earlier independence
phenotype. Because the fitness of these microbiota
is less dependent on the presence of HMO, they may
not contribute to an increase in care-eliciting behav-
iors at weaning.
EXPERIMENTAL APPROACHES TO
INVESTIGATE MECHANISTIC PATHWAYS
A multifaceted research approach, including in vitro
cultures, animal models and human studies, will be
necessary to systematically investigate a milk-
microbiota-brain-behavior (M2B2) system (Box 1;
Table 2). Identifying target ‘biobehavioral’ bacteria
that are likely to be secreting neurotransmitters is a
paramount first step [31]. Within this study system,
bacteria isolated from the infant microbiome or
‘milk-oriented microbiota’ would provide the initial
research target [24]. Infant-harbored microbial
communities, including unculturable populations,
could be examined via metagenomics to potentially
determine their ability to secrete neurotransmitter-
like molecules and their capacity to metabolize milk
constituents. Bioactive milk components can also
be identified by in vitro testing with bacterial strains
and in vivo research in model organisms [81].
Experimental administration of milk-derived mol-
ecules to dams, to be secreted in milk, instead of
directly treating neonates, is less invasive and may
have fewer stress confounds, an important consid-
eration for behavioral studies. Following identifica-
tion of target milk constituents and bacteria,
gnotobiotic animals can be inoculated with the tar-
get bacterium, treated with the bioactive and admin-
istered biobehavioral assessment [31]. Inoculation
of dams or neonates with specific, singular micro-
organisms and bioactives will provide causal mech-
anistic pathways.
Behavioral phenotype is necessarily mediated
through the brain, so neural regions that underlie
Figure 3. The relationship between constraints and less costly phenotypes. The intensity of constraints (red indicates severe;
blue indicates relaxed) on the mother–infant dyad affects the definition of a ‘less costly’ phenotype from a maternal resource
perspective. Under situations of mild constraints (A and D), less costly phenotypes will prioritize growth or behavior because
resources are not available to prioritize both. Under severe constraints (C), less costly phenotypes will be delayed in both growth
and behavior. Under relaxed constraints (B), resources can be allocated to behavior and growth.
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the development and maintenance of emotion regu-
lation and behavioral motivation, generally midbrain
areas, are likely to be implicated in the hypothesized
behavioral effects. Specifically, the hypothalamus,
anterior cingulate cortex, amygdala, insula and
hippocampus, already known to be integral compo-
nents of the gut–brain axis and developmentally sen-
sitive, are important targets of future research
of a M2B2 dynamic [44, 68, 82]. Similarly, the
serotonergic system, implicated in anxiety and de-
pression, is differentially regulated in germ-free mice
[44, 69]. Moreover, early life experiences organize
these brain systems and influence offspring behav-
ioral phenotype [83, 84]. Maternally influenced
biobehavioral microbes are likely to directly influ-
ence these regions through the infant’s gut–brain
pathway, but also indirectly through shaping the be-
havioral experiences of their host.
Proposed experiments are necessarily simplified
from the naturalistic circumstances consisting of
hundreds of milk bioactives and hundreds of mi-
crobes, but through systematic elaboration, re-
searchers can address more complex interactions.
Like the microbiota, milk bioactives may only have
certain effects in concert with other milk components
or behavioral care interactions. Observational and
epidemiological studies that grapple with these
complexities facilitate correlative patterns that can
be evaluated for consistency with and departure from
experimental findings. Although cross-population
studies of human breast milk are often characterized
by limitations in determining causality as well as
methodological obstacles, logistical complexities
and ethical considerations [85], they are necessary
to situate milk bioactives and gut bacteria within their
human evolutionary context. Employing collabora-
tive, integrative, multifactorial approaches are espe-
cially important with microbiome studies, because
the cooperation and antagonism between microbial
taxa may be a driving force in colonization and micro-
bial function [19].
CONSIDERATIONS FOR HUMAN
HEALTH
Current clinical practices can directly and indirectly
influence the presence and abundance of com-
mensal microbes during critical windows of devel-
opmental co-organization of multiple physiological
systems in the infant [1, 4]. Cesarean deliveries, for-
mula feeding and early administration of antibiotics,
all of which can dramatically alter microbial commu-
nity ecology and therefore the infant, are increasingly
commonplace in the United States and around the
world [86, 87]. Perturbations or dysbiosis of the early
gut microbiota could have unexpected and persist-
ent effects, including altered biobehavioral regula-
tion, immunological function and metabolic
processes [26, 29, 88, 89]. Ecological stressors,
mediated through interaction with the mother, influ-
ence early development and affect chronic disease
risk [41]. Exposure to microbiota in infancy at mis-
matched time points (too early or too late) may have
long-term phenotypic effects. For example,
box 1 .models of gut microbiota
Much of our understanding of mammalian-microbe interactions emerges from biomedical re-
search on animal models such as rodents and, to a lesser extent, pigs. Gnotobiotic animals are
purposely colonized by a defined set of specific bacteria or remain germ-free having been raised
and maintained in a sterile environment [4]. Models may be SPF, known to be free of particular
microbial strains [78]. Of particular utility, gnotobiotic animals may be inoculated with human
microbiota, producing ‘humanized’ models [79]. Using gnotobiotic animals permits controlled
experiments to target the molecular mechanisms and functional outcomes of milk constituents
interacting with resident microbiota. In contrast to gnotobiotic models, conventional models
maintain a microbial ecology that is not experimentally composed prior to experimentation, but
manipulated indirectly through exogenous interventions. This may include controlled diet,
stress challenges and disease state that may prompt a characteristic shift in microbial ecology
in form and/or function [43, 63, 80]. Animal models have been essential for understanding the
mechanisms by which microbial products in the gut communicate with the brain via the gut–
brain axis and provide important avenues for investigating mother’s milk, microbial ecology and
infant behavior.
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kwashiorkor and severe malnutrition are associated
with microbiota that is ‘underdeveloped’ for age in
Malawi children [90]. Here, we extend the motivation
for understanding the essential metabolic and im-
munological functions of commensal microbiota
vital for maintaining health to the implications for
behavioral phenotype, toward a more integrative de-
velopmental programming approach.
Milk bioactives and live bacteria are now increas-
ingly integrated into clinical care, especially for in-
fants in the form of nutritional supplements and
medical treatment. Many neonatal intensive care
Table 2. Research priorities and pathways for an integrative understanding of the milk-microbe-brain-be-
havior (M2B2) system. Established and ongoing research currently addresses all elements of this system, but
their integration provides new opportunities to understand adaptations in mothers and infants for negotiating
conflict and coordination of maternal investment and infant utilization of that investment.
Topics Agenda Methods/disciplines Measures
Milk
oligosaccharides
Describe presence, abundance,
sources of variation in milk
oligosaccharides profiles intra-in-
dividually, inter-individually,
across populations, across
species
Analytical Chem,
Biochemistry,
Pediatrics, Animal
Science
Milk sampling, longitudinal
Microbiota in milk Identify mode of entry to milk, ex-
plore possibilities of selective
translocation of maternal bac-
teria, determine whether milk
microbiota survives passage
through the stomach
Microbiology,
Metagenomics,
Physiology
Cultured, sterile biopsy of
mammary tissue with
analysis of maternal and
infant gut microbiota
Infant microbiota Determine presence, abundance of
microbes longitudinally, response
to perturbations
Microbiology,
Metagenomics,
Metabolomics
Fecal samples, 16S rRNA
analysis, Cultures,
Metabolic products
Milk-oriented
microbiota
Identify microbiota capable of
metabolizing human milk
Microbiology,
Metagenomics,
Biochemistry
In vitro cultures,
metagenomic analysis of
unculturable organisms
Infant behavior Assess behavioral phenotype dur-
ing the period of maternal nutri-
tional dependence, the weaning
process
Ethology, Behavioral
Ecol, Anthropology
Psychology, Human
Biology
Activity level, affect,
surgency/extraversion, vo-
calization, time spent on
mother, time spent near
conspecifics
Infant brain Evaluate neural function, receptor
density and structures in brain
regions underlying emotion regu-
lation and behavioral motivation.
Neurobiology,
Biopsychology,
Animal Science
In vivo neuroimaging, ex
vivo receptor staining,
neural mapping of re-
gions of interest
Infant gut
epithelium
Quantify receptor density and gene
expression within the gastro-
intestinal tract to determine gut–
brain axis pathways affecting
emotion regulation and behavior.
Physiology, Animal
Science
histology of neurotransmit-
ter receptors, RNASeq of
tissue in fecal samples
Maternal
outcomes
Measure maternal recovery and
transitions to subsequent repro-
duction in relation to infant be-
havioral phenotype
Evolutionary Anth,
Human Biology,
Behavioral Ecol
Metabolic cost of lactation,
inter-birth interval, dur-
ation of amenorrhea, sub-
sequent pregnancy
outcome
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units rely on donor milk sometimes augmented with
human milk fortifier and probiotics, including
lactobacilli and bifidobacteria, to reduce incidence
of necrotizing enterocolitis (NEC) [91–94]. Although
donor milk is pasteurized, killing the microbes,
HMO remain intact and bioactive [95]. Currently,
commercially available breast milk alternatives con-
tain plant-derived oligosaccharides but not HMO
[96]. Given the variation among mothers in HMO
profiles and unexplored biobehavioral effects, selec-
tion of which HMO to incorporate into infant for-
mulas is challenging. However, recently one
HMO—disialyllacto-N-tetraose—was shown to re-
duce NEC in a rodent model [97].
Microbial treatments are also gaining traction for
the remediation of behavioral and psychiatric symp-
toms. Recently, ‘psychobiotics’—live organisms,
including bifidobacteria, that diminish symptoms
of psychiatric illness—have garnered clinical atten-
tion [98]. In a rat model of depression, administra-
tion of bifidobacteria reversed depression-like
behaviors, restored normal immune response and
returned norephinephrine levels in the brainstem to
baseline [46]. Lactobacillus rhamnosus colonization
in mice reduced anxiety and affected expression of
GABA receptors [98]. In humans, administration of
Lactobacillus helveticus and B.longum reduces psy-
chological distress and alleviates symptoms of de-
pression compared with placebos [33]. More
recently, prebiotic intake in human subjects has
demonstrated decreased cortisol levels and
decreased vigilance toward negative information
[99]. As reviewed by Rook et al. [8] in this journal,
the evaluation of the ‘Old Friends Hypothesis’
across diverse populations suggests that diverse mi-
crobial exposure during development modulates in-
flammation response over the lifetime.
Downregulation of the inflammation response con-
tributes to stress resilience, while exposure to less
diverse microbes may increase risk for psychiatric
disorder in adulthood through exaggerated inflam-
mation response to social stress [8, 100].
While the evidence for bacterial therapeutics
continues to accumulate, much remains unknown,
especially regarding interventions during devel-
opment when such manipulations exert greater
phenotypic effects [30]. Aspects of this system
may reflect push–pull dynamics between mother
and offspring, a consideration rarely present in clin-
ical discussions of neonatal health management.
Applied microbiology in a clinical setting may pre-
cipitate unintended side effects for infant behavior,
but also has the potential for targeted amelioration
of undesired consequences from current medical
practices.
SUMMARY
The bioactive components in milk, produced by the
mother, may be influencing the infant microbiota to
shift the infant phenotype toward the mother’s op-
tima for investment. Research in rodents, rhesus ma-
caques and humans has already demonstrated
biobehavioral effects of milk bioactives [36]. We hy-
pothesize that other bioactives in milk, such as
HMO, are also influencing behavioral phenotype
and mediating maternal-offspring conflict and co-
ordination through gut microbiota. As the first
microbiota to colonize the infant originate from the
mother [1, 4, 20] and are fed by mother’s milk [22], it
appears that gut microbiota composition may be
susceptible to maternal manipulation. This M2B2
system is extremely complex, encompassing a multi-
tude of bacteria with more genes than the human
genome [2], hundreds of HMO [16] and physiological
and neurobiological systems of exquisite complexity.
We predict that simple, singular answers to the
phenotypic effects of mother’s milk and microbiota
interactions are unlikely. An evolutionary perspective
allows us to appreciate the essential tensions within
the mother–infant dyad and recognize that the in-
fant’s microbial ecology is a potential landscape for
negotiating conflict and maintaining coordination.
Among the many, many bacteria in the infant gut,
may be lurking mother’s littlest helpers.
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